|Day Low/High||19.12 / 19.91|
|52 Wk Low/High||11.30 / 19.81|
Highlights for 2016 Include 38% Revenue Growth, Two New Major Biopharma Diagnostic Collaborations and Substantial Progress on Pipeline of New Products and Technologies
Digital Spatial Profiling Technology Enables Spatially-Resolved, Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Tumors
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Illumina, NanoString Technologies and Kite Pharma are among the premarket movers in biotech.
Investors eyeing a purchase of NanoString Technologies Inc shares, but cautious about paying the going market price of $22.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April put at the $20 strike, which has a bid at the time of this writing of $1.20.
Assay portfolio enables simultaneous analysis of DNA, RNA, and protein for cancer research
Abstracts Demonstrate the Value of the nCounter Platform for Disease Characterization, Translational Research and Diagnostic Applications in Hematology
nCounter-based system enables multiplex analysis of proteins and RNA in spatial context from Formalin-Fixed, Paraffin-Embedded (FFPE) samples
Revenue Growth of 53% Year-Over-Year Driven by Increased nCounter SPRINT Demand and Strong Commercial Execution
Library-Free Work Flow Goes From FFPE Tissue Sample to Sequencing in Less Than 60 Minutes
nCounter® Vantage 3D™ Solid Tumor Panels Enable Simultaneous Analysis of Single Nucleotide Variations (SNVs), mRNA, Fusion Genes, and Proteins on a Single Platform
In recent trading, shares of NanoString Technologies Inc have crossed above the average analyst 12-month target price of $20.60, changing hands for $20.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Investors eyeing a purchase of NanoString Technologies Inc stock, but cautious about paying the going market price of $16.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $15 strike, which has a bid at the time of this writing of $1.05.